The startup develops a minimally invasive implant that utilizes a novel bioelectric technique to treat degenerative disc disease (DDD) by targeting the root cause of the condition. This approach enables physicians to alleviate pain and restore the normal functionality of intervertebral discs.
Funding
Funding not disclosed
Founders
Product
Problem
Degenerative disc disease (DDD) is a prevalent cause of chronic back pain, significantly impacting quality of life and affecting a large percentage of the adult population. Current treatments often address the symptoms of DDD without targeting the underlying cause, and may require hospitalization and extensive rehabilitation.
Solution
Discure Technologies has developed a minimally invasive, implantable bioelectronic device designed to treat and reverse degenerative disc disease. The device works by restoring healthy fluid dynamics within the intervertebral disc, which helps to revive disc cells and accelerate tissue healing. This approach aims to restore cushioning and stability to the spine, ultimately reducing pain and restoring function without the need for hospitalization or extensive rehab. The procedure is a short, outpatient intervention, allowing for early intervention and faster relief.
Target Audience
The primary target audience includes patients suffering from low back pain due to degenerative disc disease, as well as orthopedic surgeons and neurosurgeons specializing in spine care.
Features
- Minimally invasive implantation procedure
- No post-operative rehabilitation required
- Short outpatient procedure, eliminating the need for hospitalization
- Designed to restore disc health, mobility, and function
- Aims to reverse disc degeneration by restoring healthy fluid dynamics
- No recharging or manual adjustments needed
- Granted FDA Breakthrough Device designation